The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

In 2026, clinical trial teams market uncertainty and identify high-impact areas for AI adoption to remain competitive.

Identifying copyright holders and response times are major challenges in COA licensing, causing delays in clinical trials. Clear documentation of copyright ownership and standardized response times ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Beena Wood, Qinecsa, saw 2025 as an AI superposition in which pharmacovigilence needed better data foundations and regulation ...

After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...

On Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held ...

A Missouri House candidate’s history of domestic violence. A Highway Patrol trooper’s sexual abuse of a fellow officer at a ...

Dr Benson, Robert H. Lurie Comprehensive Cancer Center, explores the importance of philanthropy and the power it has to drive ...